How Changing the Reporting Period for Public Companies to Semiannual Could Impact the D&O Market

Last week the issue of public companies having to do quarterly reports popped up in the news in a big way with the President tweeting and then speaking on the possibility of ending quarterly reporting.  There are a lot of opinions out there on whether this is a good idea or bad idea.  Some people … Continue reading How Changing the Reporting Period for Public Companies to Semiannual Could Impact the D&O Market

Not Sure The IRS Agrees With a Tax Position Your Company Has Taken? Here is a Solution

I recently read that Illinois Tool Works (ITW) prevailed in a case against the IRS.  The IRS challenged that a loan from ITW’s foreign subsidiary to its parent company was a nontaxable return of capital as ITW contended.  The IRS dtermined that it was not a loan but a dividend and as a result a … Continue reading Not Sure The IRS Agrees With a Tax Position Your Company Has Taken? Here is a Solution

Your Insurance Broker Has No Incentive to Retain You as a Client!!!!

Skin in the game – that means your insurance broker actually having a vested interest in your success and the level of service you receive year in and year out.  Skin in the game does not mean your broker having a greater financial interest in year one compared to subsequent years yet that is how … Continue reading Your Insurance Broker Has No Incentive to Retain You as a Client!!!!

Why Securities Class Filings are a Reality for Publicly Traded Companies

Cornerstone Research always puts out great data and this report on Securities Class Action Filings for the first half of 2018 is no exception.  I recommend you check out the full report which you can find here. These visuals really speak for themselves but the big takeaway is that if you are publicly traded company … Continue reading Why Securities Class Filings are a Reality for Publicly Traded Companies

Friday Morning’s Top Articles

Happy Friday!  Here is what I am reading as we head into the weekend: Talk about hitting on a lot of points, super insightful article - Regeneron’s Billionaire Founder Battles The Drug Pricing System (Forbes). Bio Roundup: An Alzheimer’s Head-Scratcher, OUTBio, GSK & Gilead Shakeups (Xconomy) When healthcare devices go over the counter. An important … Continue reading Friday Morning’s Top Articles

Monday Morning Healthcare News

It's a new week and this is what I'm reading to get going: While Tech Waffles On Going Public, Biotech IPOs Boom (Crunchbase) Smart Bandage Can Dispense Drugs, While Keeping An Eye On Your Wound (FORBES) Tendyne investors sue Abbott over $50m milestone (MassDevice). In case you missed, my thoughts on how a company can … Continue reading Monday Morning Healthcare News

Why Milestone Payments Go Uninsured

Almost every day I read about a company receiving a milestone or grant payment, but sometimes milestones aren't met and it is not for lack of science. I often wonder how a company would be affected if the milestone or grant were not received because of a fire or some other natural event rather than the … Continue reading Why Milestone Payments Go Uninsured